Chiimatherapeutics
Founded 2021 · 2 employees on LinkedIn · 1 known investors
Chiima Therapeutics is a biotech company developing first-in-class, non-hormonal therapies for women's health conditions with unmet needs, including endometriosis, pre-term labor, and PCOS. Its pipeline covers investigational compounds addressing diseases that affect women worldwide.
Investors · 1
Competitors · 2
by search overlap
Kymera Therapeutics3 shared keywordsKymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins. The company focuses on advancing small molecule therapies designed to address critical health problems across multiple disease areas.
Kimia3 shared keywordsKimia develops a drug discovery platform called ATLAS that combines active learning, automated chemical synthesis, high-throughput screening, and machine learning to design and optimize novel drug molecules. The company generates large-scale chemical and biological datasets to map the relationship between chemical structure and protein function for generative drug design.
Companies competing with Chiimatherapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Chiimatherapeutics do?
- Chiima Therapeutics is a biotech company developing first-in-class, non-hormonal therapies for women's health conditions with unmet needs, including endometriosis, pre-term labor, and PCOS. Its pipeline covers investigational compounds addressing diseases that affect women worldwide.
- Who are Chiimatherapeutics's investors?
- Chiimatherapeutics's investors include The Innovation Space.